RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. FCF margin (%)

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$108.9B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 2024-7.2-121.21%
Dec 31, 202333.8-23.07%
Dec 31, 202244+38.22%
Dec 31, 202131.8-34.09%
Dec 31, 202048.2+34.43%
Dec 31, 201935.9-6.90%
Dec 31, 201838.5+28.68%
Dec 31, 201730+184.01%
Dec 31, 201610.5-126.51%
Dec 31, 2015-39.8-59.08%
Dec 31, 2014-97.2+1044.62%
Dec 31, 2013-8.5-165.95%
Dec 31, 201212.9+66.49%
Dec 31, 20117.7-101.65%
Dec 31, 2010-469.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)